This research was supported by Science Foundation Ireland (grant no. 08/IN.1/B1843 and CSET grant no. 07/CE/B1368) and the Marie Curie International Re-integration Grant programme. The authors have no conflicts of interest to declare. Fig. S1. Bcl-3 mRNA levels in normal (N, n = 11), Crohn’s disease (CD, n = 10) and ulcerative colitis (UC, n = 10) colon tissue. Data extracted from the NCBI GEO data set GDS1330. Fig. S2. Relative levels of cleaved caspase-3 normalized

to β-actin levels in colon tissue from untreated (open bars) and dextran-sodium sulphate (DSS)-treated (filled bars) wild-type and Bcl-3−/−. Levels were quantified form immunoblot analysis presented in Fig. 6b in the main text. “
“Additional progression markers for human immunodeficiency virus (HIV) infection are warranted. In this study we related antigen-specific responses in CD4+ and CD8+ T cells click here to CD38, reflecting chronic immune activation, and to CD4+ T cell loss rates. Clones transiently expressing CD107a (CD8+) or CD154 (CD4+) in response to Gag, Env

and Nef overlapping peptide pools were identified, along with their expression of the inhibitory programmed death-1 receptor (PD-1) in fresh peripheral blood mononuclear cells (PBMC) from 31 patients off antiretroviral treatment (ART). HIV-specific CD8+ T cell responses dominated over CD4+ T cell responses, and among CD8+ responses, Gag and Nef responses were higher than Env-responses (P < 0·01). PD-1 on CD8+ HIV-specific subsets was higher than CMV-specific CD8+ cells (P < 0·01), whereas PD-1 on HIV-specific CD4+ cells was similar to PD-1 NVP-BEZ235 molecular weight on CMV-specific CD4+ cells. Gag and Env CD8+ responses correlated oppositely to the CD4 loss rate. Env/Gag CD8+ response ratios, independently of PD-1 levels, correlated more strongly to CD4 change rates (r = −0·50 to −0·77, P < 0·01) than the total number of

Gag-specific CD8+ cells (r = 0·44–0·85, P ≤ 0·02). The Env/Gag ratio performed better than CD38 and HIV-RNA in logistic regression analysis predicting CD4 change rate as a measure of progression. In conclusion, HIV-specific CD8+CD107a+ Env/Gag response ratio was Ribose-5-phosphate isomerase a stronger predictor for progression than CD38 and HIV-RNA. The Env/Gag ratio may reflect the balance between possibly beneficial (Gag) and detrimental (Env) CD8+ T cell responses and should be explored further as a progression marker. Anti-retroviral treatment (ART) effectively reverses immune deficiency in human immunodeficiency virus (HIV)-infected individuals who have HIV-related symptoms or opportunistic infections; however, the immune system is better preserved when ART is started early in an asymptomatic phase [1]. For such patients, low current CD4+ T cell counts have predominated as an indication for ART, accompanied by secondary criteria such as rapid CD4 decline or high HIV-RNA concentrations [2–5].